Psychiatrists and Psychologists
Andrew A. Nierenberg, MD - Director
Andrew Nierenberg, MD, graduated from the Albert Einstein College of Medicine of Yeshiva University, Bronx, NY. After completing his residency in psychiatry at New York University/Bellevue Hospital, he studied clinical epidemiology at Yale University as a Robert Wood Johnson Clinical Scholar. Dr. Nierenberg then joined the faculty at Harvard Medical School, first at McLean Hospital in Belmont, Massachusetts and then at Massachusetts General Hospital, where he is currently Director of the Dauten Family Center for Bipolar Treatment Innovation, Associate Director of the Depression Clinical and Research Program, Director of Training and Education of the MGH Research Institute, Professor of Psychiatry at Harvard Medical School, and the Thomas P. Hackett, MD Endowed Chair in Psychiatry at MGH. He is also Honorary Professor in the School of Medicine, Faculty of Health at Deakin University, Geelong Australia. Dr. Nierenberg’s primary interests are depression, bipolar depression, and novel treatments.
Dr. Nierenberg has published over 475 papers and has been listed in The Best Doctors in America for the treatment of mood and anxiety disorders in every edition since 1994. From 2014 to 2017, he was listed among the World’s Most Influential Scientific Minds by Thompson Reuters in recognition of ranking among the top 1% of researchers for most cited papers in psychiatry worldwide. He is currently the principal investigator for the Patient Centered Outcomes Research Institute (PCORI) MoodNetwork. The goal of MoodNetwork is to improve the lives of people with mood disorders by establishing a network of at least 20,000 patients across the country to conduct patient-centered comparative effectiveness research studies.
Thilo Deckersbach, PhD – Associate Director
Thilo Deckersbach, PhD, is the Associate Director of the Dauten Family Center for Bipolar Innovation at MGH and the Associate Director of the Division of Neurotherapeutics at MGH. He is also the Director of the Graduate Student Division at MGH, which includes over 600 graduate students from local and international graduate schools. He is an Associate Professor of Psychology at Harvard Medical School. Dr. Deckersbach graduated from the Philipps University of Marburg, Germany in 2000 and completed his clinical psychology internship in the Cognitive-Behavior Science Track at the Massachusetts General Hospital/Harvard Medical School. He specializes in the development of new psychosocial treatments in bipolar disorder (e.g. mindfulness-based cognitive therapy) and neuroimaging and neuromodulatory techniques to investigate brain functioning in bipolar disorder.
Louisa Grandin Sylvia, PhD – Director of Psychology
Louisa Sylvia, PhD, is the Director of Psychology at the Dauten Family Center for Bipolar Treatment Innovation. She is also the Director of Health and Wellness for the Red Sox Foundation and MGH Home Base Program which aims to heal the invisible wounds of wars for veterans and their families. Dr. Sylvia is an Associate Professor of Psychology at Harvard Medical School. Dr. Sylvia’s major research interests are developing psychosocial interventions for bipolar disorder, particularly improving the management of exercise, nutrition, and sleep in this clinical population. Dr. Sylvia has published many peer-reviewed manuscripts in her area of specialization as well as presented her work at numerous local, national and international conferences. She has also co-authored the Bipolar II Disorder Workbook and wrote the Wellness Workbook for Bipolar Disorder, a guide to getting healthy and improving mood. Dr. Sylvia received her Bachelor of Arts degree with honors from Wesleyan University in Middletown, CT. She received her doctoral degree in Clinical Psychology at Temple University in Philadelphia, PA and completed her psychology internship at McLean Hospital in Belmont, MA.
Michael Henry, MD – Medical Director
Michael Henry, MD, is the Medical Director of the Dauten Family Center for Bipolar Treatment Innovation. Prior to joining the DFC, he was the vice-president for mental health at Steward Health Chair and the Chairman of Psychiatry at St. Elizabeth's Medical Center, as well as an Associate Professor of Psychiatry at Tufts Medical School. Dr. Henry’s research interests have been focused on the use of brain imaging techniques to study mood disorders and facilitate drug discovery. He has published journal articles and book chapters as well as presented his work both nationally and internationally. In addition to research, Dr. Henry enjoys teaching. He received recognition for his outstanding teaching from the Tuft’s University Medical Students and received the annual teaching award from the St. Elizabeth's Psychiatry Residents in 2010. As the Medical Director, he is excited to be continuing his work in teaching, direct patient care, as well as expand his research activities at this institution with world-class collaborators.
Astrid Desrosiers, MD, MPH
Astrid Desrosiers, MD, MPH is an Assistant Professor in Psychiatry at Harvard Medical School, a Lecturer in Psychiatry at the University of Cape Coast Health and Medical Sciences, Cape Coast, Ghana, Africa. She is a staff psychiatrist in the Dauten Family Center and is involved in clinical research and treatment of patients. She obtained her medical degree from the State University of Haiti. She completed her training in Psychiatry at the Cambridge Hospital Adult Psychiatry Training Program. She completed her training in Adult Psychiatry through the Harvard Medical School Consolidated Training Program: Harvard South Shore Training Program and Cambridge Hospital in 1995. Dr. Desrosiers has a Master in Public health and a certificate in Global Mental health from Harvard University. Dr. Desrosiers is the Medical Director of the Haitian Mental Health Clinic at the Cambridge Health Alliance in Cambridge, Massachusetts. Dr. Desrosiers is a Diplomate of the American Board of Psychiatry and Neurology. Her major research interests include psychopharmacology, the role of psychosocial factors in the treatment of Mood Disorders, health disparities and the impact of Multicultural issues on patient care. Dr. Desrosiers also serves as the chair of the Massachusetts Psychiatric Society Multicultural/Diversity committee.
Kristen K. Ellard, PhD
Kristen K. Ellard, PhD, is a Instructor in Psychology at the Dauten Family Center for Bipolar Treatment Innovation. She completed her doctoral training at Boston University, and her Clinical Internship in Psychology at MGH. Her clinical work focuses on the use of cognitive behavioral therapy (CBT) for the treatment of anxiety and mood disorders. Dr. Ellard’s primary research interests are in the investigation of new CBT approaches to the treatment of bipolar disorder with co-occurring anxiety disorders, characterizing neural mechanisms of change in cognitive behavioral therapy, and exploring neural correlates of transdiagnostic versus disorder-specific cognitive and affective processing in the emotional disorders.
Sharmin Ghaznavi, MD, PhD
Sharmin Ghaznavi, MD, is a staff psychiatrist for the Dauten Family Center for Bipolar Treatment Innovation. Dr, Ghaznavi completed her MD, PhD at the Yale University School of Medicine Medical Scientist Training Program. She holds a PhD in Neuroscience and a MA in Philosophy. Dr. Ghaznavi completed her adult psychiatry residency training at the MGH/McLean Adult Psychiatry Residency Training Program, where she was a resident in the Research Concentration Program. Dr. Ghaznavi is a recipient of the Thomas P. Hackett Award for outstanding academic research and achievement during residency, and the Joyce and Richard Tedlow award for her efforts to integrate psychotherapy, psychopharmacology and clinical research during residency. Dr. Ghaznavi is pursuing research on the neural correlates of rumination in bipolar disorder, with funding from the Dupont-Warren and Livingston Psychiatry Research fellowships through Harvard Medical School and a NARSAD Young Investigator Award from the Brain and Behavior Research Foundation. Related to her research, Dr. Ghaznavi also serves as Director of the Cross Program Research Initiative on Rumination for the department.
Douglas Katz, PhD
Douglas Katz, PhD, is a staff psychologist at the Dauten Family Center for Bipolar Innovation and the Primary Care Psychiatry practice at Massachusetts General Hospital, and an Instructor at Harvard Medical School. Dr. Katz’s main clinical interests are the use of mindfulness-based cognitive therapy (MBCT), cognitive behavioral therapy (CBT) and dialectical behavior therapy (DBT) in the treatment of mood and anxiety disorders. His primary research interest is the development of new treatments for individuals with bipolar disorder and comorbid PTSD. Dr. Katz received his undergraduate degree from University of Colorado, in Boulder, CO, and his doctoral degree from Fordham University in the Bronx, NY.
Masoud Kamali, MD
Masoud Kamali, MD, is a staff psychiatrist for the Dauten Family Center for Bipolar Treatment Innovation. Dr. Kamali is a graduate of Tehran University of Medical Sciences and completed his residency at St. Luke’s-Roosevelt hospital in NYC. He joined MGH in 2015 from the University of Michigan, where he completed a research fellowship and was on the faculty, doing research on bipolar disorder, impulsivity, and suicidal behavior. Dr. Kamali also serves as a staff psychiatrist on Blake 11, MGH’s inpatient psychiatric unit. He is closely involved in the clinical training and supervision of medical students and psychiatry residents, during their rotations on inpatient psychiatry. He has been an author of over 40 journal articles, research manuscripts and book chapters. He has also been an investigator on multiple clinical research projects, including treatment trials and investigational studies of bipolar disorder and suicidal behavior. His research interests include better understanding the longitudinal course and outcomes of bipolar disorder, and recognizing and reducing the risk factors for suicide in this population.
Gustavo Kinrys, MD
Gustavo Kinrys, MD, is a staff psychiatrist, the Associate Medical Director for the Dauten Family Center for Bipolar Treatment Innovation as well as for MGH Clinical Trials Network and Institute. Dr. Kinrys is a graduate from the Mayo Clinic Graduate School . Prior to coming to MGH, Dr. Kinrys served as the Director of the Mood and Anxiety Disorders Research Program and the Psychopharmacology Research Program, and the Medical Director of the Portuguese Mental Health Clinic at the Cambridge Health Alliance, Harvard Medical School . Dr. Kinrys is an investigator on studies funded by the National Institutes of Mental Health and the Agency for Healthcare Research and Quality involving the course of Bipolar disorder and Major depressive disorder. He is also an investigator in numerous phase I, phase II, and phase III clinical trials sponsored by the pharmaceutical industry. He has published over 100 articles, reviews and posters and he lectures in national and international forums. Dr. Kinrys has been the principal investigator in over 80 clinical trials. His areas of interest include treatment resistant depression, bipolar and anxiety disorders, development of novel pharmacologic agents for mood and anxiety disorders, cross-cultural and minority issues in clinical trials, and uses of natural remedies alone and combined with conventional pharmacologic therapies for treatment-refractory patients.
Noreen Reilly-Harrington, PhD
Noreen Reilly-Harrington, PhD, is staff psychologist for the Dauten Family Center for Bipolar Treatment Innovation and an Assistant Professor of Psychology at Harvard Medical School. Dr. Reilly-Harrington is an internationally recognized expert in the cognitive-behavioral treatment of mood and anxiety disorders, with a particular expertise in treating bipolar disorder. She has co-authored several books on bipolar disorder, including "Bipolar Disorder: A Cognitive Therapy Approach," "Living with Bipolar Disorder: A Guide for Individuals and Families," and "The Bipolar II Disorder Workbook: Managing Recurring Depression, Hypomania, and Anxiety." She has served as the Director of Training and Assessment for the Bipolar Trials Network and has consulted on numerous studies to improve the reliability of clinical assessments Dr. Reilly-Harrington also serves on the staff of the MGH Weight Center, with a special focus on the treatment of obesity and eating disorders in individuals with mood disorders. Dr. Reilly-Harrington earned her undergraduate degree at the University of Pennsylvania and her doctoral degree at Temple University. She trained in cognitive therapy under the direction of Dr. Aaron T. Beck at the Center for Cognitive Therapy, University of Pennsylvania and at the Beck Institute for Cognitive Therapy and Research. She completed both her pre-doctoral internship and post-doctoral fellowship in Cognitive Behavioral Therapy at MGH/Harvard Medical School and is a Founding Fellow in the Academy of Cognitive Therapy.
Gary Sachs, MD
Gary Sachs, MD, is Associate Clinical Professor in Psychiatry at Harvard Medical School and a Clinical Vice President at Bracket. Dr. Sachs was the Founding Director of the Bipolar Clinic and Research Program at Massachusetts General Hospital and founder of the Collaborative Care Initiative. As Principal Investigator of the National Institute of Mental Health Systematic Treatment Enhancement Program for Bipolar Disorder , Dr Sachs led the largest treatment study ever conducted for bipolar disorder. Dr. Sachs serves on the board of directors for the Depression and Bipolar Support Alliance and Co-chairs the DBSA scientific advisory board. He has authored over 200 articles, abstracts, books, reviews, and book chapters. He is a distinguished fellow of the American Psychiatric Association and is recognized as a “Top Doctor” by US News and World Report, and by Reuters as among the world’s 100 most influential Psychiatrists, Neurologists and Neuroscientists. As a recipient of an NIH Small Business Innovative Research Grant, he founded Concordant Rater Systems and holds patents for methods to improve endpoint reliability in clinical trials. He currently focuses his work on clinical trial methodology, innovative approaches to clinical practice and patient-centered research.
Brian Schulman, MD
Brian Schulman, MD, is a staff psychiatrist for the Dauten Family Center for Bipolar Treatment Innovation. Dr. Schulman trained at the University of California, San Francisco (UCSF) School of Medicine and completed his adult psychiatry residency at the Harvard-affiliated joint MGH/McLean program. Dr. Schulman is interested in combining psychopharmacological treatment of bipolar disorder with psychotherapeutic approaches. He is actively involved in medical student and residency level education. He is also pursuing advanced training in psychoanalytic psychotherapy from the Boston Psychoanalytic Society and Institute.
Tae-Sung Yeum, MD
Tae-Sung Yeum, MD, is a clinical research fellow at the Massachusetts General Hospital Dauten Family Center for Bipolar Treatment Innovation. He graduated from Seoul National University College of Medicine and completed his psychiatry residency at Seoul National University Hospital in South Korea. His main research interests are mood disorders and suicide behaviors. During his fellowship at the Dauten Center, he is involved in research projects aimed at improving future treatment of bipolar disorder.
Jake Dinerman, BA
Jake Dinerman, BA, graduated summa cum laude from Clark University in May 2016 and as a member of Phi Beta Kappa. During the summer of 2014, Jake interned in the adolescent partial unit at Bradley Hospital in Providence, RI, where he assisted with group therapy and in a therapeutic milieu. Jake worked in the lab of Dr. Laura McKee assisting with the evaluation the effectiveness of Cognitive Bias Modification and Positive Psychology on college students’ well-being. Jake also worked in Dr. Phoebe Moore’s lab at the University of Massachusetts Medical Center. In Dr. Moore’s lab, he conducted research on the effectiveness of Acceptance and Commitment Therapy on parents of children with anxiety disorders. After his time at the DFC, Jake hopes to attend graduate school in clinical psychology.
Clinical Research Coordinators
Brett Davis, BA
Brett Davis, BA, graduated with honors from Harvard University in 2017. While at Harvard, he worked in the labs of Joshua Buckholtz, Daniel Gilbert, and Jim Sidanius. Between these labs, Brett has proposed, designed, and administered experimental protocol; assisted a meta-analysis; and conducted thorough, systematic literature searches. He intends to pursue a clinical psychology doctoral program that will allow him to study the evolutionary mechanisms at work in mood and anxiety disorders.
Selen Amado, BA
Selen Amado, BA, is a clinical research coordinator at the Massachusetts General Hospital Dauten Family Center for Bipolar Treatment Innovation and an administrator for the Health eHeart study. She is particularly interested in the development and treatment of mood and anxiety disorders as well as understanding the role of culture in treatment. After her time at the Massachusetts General Hospital, Selen plans to pursue a doctoral degree in Clinical Psychology.
Marina Rakhilin, BS
Marina Rakhilin, B.S., is a clinical research coordinator at the Massachusetts General Hospital Dauten Family Center for Bipolar Treatment Innovation. Marina is especially interested in balancing efficacy and accessibility when it comes to mental health treatment or resources, and finds the MoodNetwork to have great potential for furthering community-based and person-centered care for mood disorders.
Sophie Greenebaum, BS
Sophie Greenebaum, B.A., is a clinical research coordinator at the Massachusetts General Hospital Dauten Family Center for Bipolar Treatment Innovation (formerly the Bipolar Clinic and Research Program) and MoodNetwork’s outreach administrator. She is specifically interested in involving underserved populations in research, as well as implementing plans for accessible and thoughtful care for all people. She believes that MoodNetwork has the possibility to reach these populations, due to its navigable and free content and resources. After her time at Massachusetts General Hospital, she hopes to pursue a doctoral degree in clinical psychology.
Elizabeth Cory, BS
Liz Cory, BS, is a clinical research coordinator at the Massachusetts General Hospital Dauten Family Center for Bipolar Treatment Innovation. She works as MoodNetwork’s project administrator. Liz is interested in extending her interest in affective neuroscience to researching novel treatment methods for mood disorders. Liz is eager to see MoodNetwork strengthen the connection between patient experiences and research design. After her time at MGH, Liz plans to pursue either an M.D. or a PhD in psychology.
Former Research Coordinators
Steven Dufour, BA
Steven Dufour, BA, graduated Summa Cum Laude from Boston University majoring in Psychology and a minor in statistical methods. As an undergraduate, he worked in the research lab of Dr. David Barlow assisting with research on transdiagnostic approaches to the treatment of emotional disorders. During his senior year, he conducted his honors thesis under the mentorship of Dr. Todd Farchione in the same lab assessing the feasibility and efficacy of an online intervention for the prevention of anxiety and depression in undergraduates. Additionally, Steven helped with several projects aiming to improve treatment for veterans with post-traumatic stress disorders as an undergraduate volunteer at the Boston VA under Drs. Shannon Wiltsey-Stirman and Cassidy Gutner. Steven is interested in researching transdiagnostic treatment for emotional and traumatic disorders as well as studying statistical methods to better understand idiographic applications of particular protocols. He plans to pursue a PhD in clinical psychology following his time at Massachusetts General Hospital.
Jessica Janos, BA
Jessica Janos, BA, graduated with honors from the University of Miami in May 2016. As an undergraduate, she gained research experience in Dr. Jill Ehrenreich May’s Child and Adolescent Mood and Anxiety Treatment Program, where she completed her senior honors thesis on barriers to treatment in a clinical sample of youth with internalizing disorders. Under Dr. Ehrenreich-May’s guidance, she gained experience administering diagnostic assessments to children and adolescents with anxiety and mood disorders. Jessica is particularly interested in child psychology, and after her time at the DFC, she plans to pursue her PhD in clinical psychology.
Samantha Walsh, BS
Samantha Walsh, BS, graduated summa cum laude from the University of Miami in May 2016 majoring in Psychology with a minor in Biology. Samantha was as a member of Phi Beta Kappa and Psi Chi honor societies as well as was recognized by the College of Arts and Sciences as an outstanding senior. While completing her degree, Samantha worked in Dr. Amanda Jensen-Doss’s lab, conducting research on evidence-based treatment and assessment implementation. She also worked in Dr. Jill Ehrenreich-May’s Child and Adolescent Mood and Anxiety Treatment (CAMAT) program, studying treatment approaches for mood and anxiety disorders in youth. During her senior year, Samantha developed a senior honors thesis under the mentorship of Dr. Amanda Jensen-Doss, examining leadership and its importance in implementing an evidence-based practice using a community-based learning collaborative implementation model. Samantha is interested in studying the development and treatment of mood disorders and plans to pursue a PhD in Clinical Psychology after her time at the DFC.
Abigail Stark, MS
Abigail Stark, MS, graduated cum laude from Williams College in 2012 with a B.A. in Psychology and English. She received her M.S. in Clinical Psychology in 2014 and currently is a fourth year Clinical Psychology doctoral student at Suffolk University. Her clinical experience has focused thus far on the use of cognitive behavioral therapy and acceptance based therapy for anxiety disorders across the developmental lifespan. She has previous clinical experience at the MGH Obsessive Compulsive Disorder Clinic, McLean Obsessive Compulsive Disorder Institute Jr., McLean Anxiety Mastery Program as well as neuropsychological assessment. Abigail’s research focuses on peer aggression and exclusion and their impact on mood and anxiety. Specifically, her dissertation research focuses on cognitive frames and their impact on behaviors and emotions after bullying experiences. She has also aided in research on treatment studies including the role of exercise in symptoms of depression and treatment mechanisms of exposure therapy for anxiety disorders.
Esther Tung, MA
Esther Tung, MA, is a clinical practicum student at the Dauten Family Center for Bipolar Treatment Innovation. She is also a third-year doctoral student in clinical psychology at Boston University. Her clinical work has been largely focused in cognitive behavioral therapy (CBT) for anxiety and mood disorders. Her primary research interests are in psychopathology, the classification of anxiety and mood disorders, statistical methodology, and transdiagnostic risk factors.